New Drug Pricing Strategies for a Changing Global Market

Biopharmaceutical companies are increasingly challenged to create a drug pricing strategy that both rewards value and innovation, and promotes affordability and access. During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues, including:
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Digital Transformation in Pharma Manufacturing

No longer just a catch phrase, digital transformation in pharma manufacturing is more critical today than ever before and the industry is getting on board.
Watch Now

HHS OIG Proposed Rule on the Safe Harbor for Pharmaceutical Rebates: The Issues and Impact

ebglaw

In this on-demand webinar, we discuss the key takeaways of the proposed rule, including its potential impact, if finalized, on various stakeholders, including PBMs, health plans, drug manufacturers, and pharmacies.
Watch Now

Bridging the gap between ortho and restorative treatment

Invisalign GO

The practitioner who wishes to get started in GDP orthodontics faces a bewildering array of choices: clear aligners or fixed appliances? Which product is best to get started with? How to overcome one’s poor foundation of orthodontic knowledge from undergraduate training, when much of the information learned for final exams has subsequently been forgotten? Since 2001, the Invisalign product has been used to treat over 5 million cases worldwide. This vast bank of clinical experience is constantly used to refine and improve the product, and also makes the Invisalign system the most streamlined experience for a new user who is improving their orthodontic skills and the safest place to re-start one’s journey in orthodontics.
Watch Now

Accelerating patient recruitment in clinical trials post COVID-19

Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market.
Watch Now

Spotlight

resources